Countdown to WBC 2026 in Hannover
Welcome
A decade on from the inaugural World Bronchiectasis Conference in Hannover (2016), our community returns to the city where this global movement began. Over these ten years, bronchiectasis has moved from the margins to the mainstream: international registries have transformed understanding of disease burden and phenotypes; updated guidelines and consensus statements have clarified standards of care; new clinical trials have tested anti‑inflammatory and anti‑infective strategies; airway clearance science and physiotherapy have evolved; and digital health, imaging and microbiome research are reshaping how we monitor, personalise and prevent exacerbations. The patient voice is now firmly embedded in research priorities and service design.
WBC 2026 will gather clinicians, scientists, allied health professionals, patient leaders and industry to translate this progress into better outcomes. Expect cutting‑edge sessions on treatable traits and endotypes, infection and NTM management, precision diagnostics, paediatrics and transition, physiotherapy and rehabilitation, real‑world data and AI‑enabled tools, as well as late‑breaking trials and implementation science. Hannover provides not only a symbolic homecoming but also a watershed moment to set the agenda for
the next decade-accelerating therapeutic development, harmonising outcome measures and ensuring equitable access to high‑quality care worldwide.
We invite you to partner with us in Hannover, 24–27 June 2026, to advance the science, elevate clinical practice and improve the lives of people living with bronchiectasis.
Francesco Blasi, James Chalmers, Jessica Rademacher, Felix Ringshausen
WBC 2026 Organising Committee
Hannover, Germany

Organising Association

Important dates
REGISTRATION AND CALL FOR ABSTRACTS OPENING
October 2026
CALL FOR ABSTRACTS CLOSING
27 March 2026
EARLY REGISTRATION DEADLINE
18 April 2026
Topics
Dive into key topics at the World Bronchiectasis Conference, where we explore the complexities of bronchiectasis from its causes and underlying mechanisms to innovative treatments. Engage with cutting-edge research on genomics, diverse infections, the impact of environmental factors, and the latest therapeutic strategies.
Join global experts in addressing critical aspects of respiratory health in Hannover.
Basic Science
(aetiology & pathophysiology)
Clinical Trials
Comorbidities
(AATD, Asthma, COPD, etc.)
Cystic Fibrosis and Bronchiectasis
Immunology & Inammation
(including ABPA, inborn errors of immunity, primary
immunodeciency, neutrophil function/dysfunction)
Infections
(Pseudomonas, Haemophilus, etc.)